drug
imlunestrant tosylate
Marketedupdated 3mo agoby Eli Lilly and Co
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Unknown, with 1 investigational indication.
all catalysts(1)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 25, 2030
~4.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Jul 11, 2039compositionUS 10654866
- Jul 11, 2039compositionUS 11117902
FDA exclusivities (1)
- Sep 25, 2030NCENew Chemical Entity (5y)4.1y
News(1)
- Arvinas, Pfizer find new partner for ‘Protac’ breast cancer drugA deal with Rigel Pharmaceuticals ends months of uncertainty about the future of Veppanu, a first-of-its-kind, newly approved medicine with a murky financial outlook.biopharma_dive · 3mo ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that